Histamine H 1 receptor blockade predominantly impairs sensory processes in human sensorimotor performance

British Journal of Pharmacology

Volumn 157, Issue 1, 2009, Pages 76-85

  Van Ruitenbeek, P ^a   Vermeeren, A ^a   Smulders, F T Y ^a   Sambeth, A ^a   Riedel, W J ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Additive factor method; Benzodiazepines; Event related potentials; Histamine h 1 antagonists; Motor; Reaction time; Sedation; Sensorimotor performance; Sensory

Indexed keywords

DEXCHLORPHENIRAMINE; HISTAMINE H1 RECEPTOR; LORAZEPAM; PLACEBO; CHLORPHENIRAMINE; HISTAMINE H1 RECEPTOR ANTAGONIST;

ADULT; ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; ELECTROENCEPHALOGRAM; EVENT RELATED POTENTIAL; FEMALE; HUMAN; HUMAN EXPERIMENT; LATENT PERIOD; MALE; NORMAL HUMAN; PRIORITY JOURNAL; REACTION TIME; SCHIZOPHRENIA; SENSORIMOTOR CORTEX; TASK PERFORMANCE; ADOLESCENT; CROSSOVER PROCEDURE; DECISION MAKING; DOUBLE BLIND PROCEDURE; DRUG EFFECT; ELECTROENCEPHALOGRAPHY; EVOKED RESPONSE; PHOTOSTIMULATION; PSYCHOMOTOR PERFORMANCE;

ADOLESCENT; ADULT; CHLORPHENIRAMINE; CHOICE BEHAVIOR; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; ELECTROENCEPHALOGRAPHY; EVOKED POTENTIALS; FEMALE; HISTAMINE H1 ANTAGONISTS; HUMANS; LORAZEPAM; MALE; PHOTIC STIMULATION; PSYCHOMOTOR PERFORMANCE; REACTION TIME; YOUNG ADULT;

EID: 67149084971     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/j.1476-5381.2008.00103.x     Document Type: Article

References (57)

1. Beauducel A, Brocke B, Leue A (2006). Energetical bases of extraversion: effort, arousal, EEG, and performance. Int J Psychophysiol 62 (2): 212-223. (Pubitemid 44441601)
2. Bond A, Lader M (1974). The use of analogue scales in rating subjective feelings. Br J Med Psychol 47: 211-218.
3. Bond A, Lader M, Shrotriya R (1983). Comparative effects of a repeated dose regime of diazepam and buspirone on subjective ratings, psychological tests and the EEG. Eur J Clin Pharmacol 24 (4): 463-467.
4. Bonin-Guillaume S, Blin O, Hasbroucq T (2004). An additive factor analysis of the effect of depression on the reaction time of old patients. Acta Psychol (Amst) 117 (1): 1-11. (Pubitemid 39056452)
5. Bower EA, Moore JL, Moss M, Selby KA, Austin M, Meeves S (2003). The effects of single-dose fexofenadine, diphenhydramine, and placebo on cognitive performance in flight personnel. Aviat Space Environ Med 74 (2): 145-152. (Pubitemid 36159994)
6. Chauncey K, Grainger J, Holcomb PJ (2008). Code-switching effects in bilingual word recognition: a masked priming study with eventrelated potentials. Brain Lang 105 (3): 161-174.
7. Curran HV (2000). Psychopharmacological approaches to human memory. In: Gazzaniga MS (ed.). Cognitive Neuroscience. The MIT Press: Cambridge, MA, pp. 797-804.
8. Curran HV, Pooviboonsuk P, Dalton JA, Lader MH (1998). Differentiating the effects of centrally acting drugs on arousal and memory: an event-related potential study of scopolamine, lorazepam and diphenhydramine. Psychopharmacology (Bert) 135 (1): 27-36. (Pubitemid 28055447)
9. Dickman SJ, Meyer DE (1988). Impulsivity and speed-accuracy tradeoffs in information processing. J Pers Soc Psychol 54 (2): 274-290.
10. Esbenshade TA, Fox GB, Cowart MD (2006). Histamine H3 receptor antagonists: preclinical promise for treating obesity and cognitive disorders. Mol Interv 6 (2): 77-88.
11. Fine BJ, Kobrick JL, Lieberman HR, Marlowe B, Riley RH, Tharion WJ (1994). Effects of caffeine or diphenhydramine on visual vigilance. Psychopharmacology (Bert) 114 (2): 233-238. (Pubitemid 24152111)
12. Frowein HW (1981). Selective effects of barbiturate and amphetamine on information processing and response execution. Acta Psychol (Amst)47 (2): 105-115.
13. Frowein HW, Gaillard AW, Varey CA (1981). EP components, visual processing stages, and the effect of a barbiturate. Biol Psychol 13: 239-249.
14. Gaillard AWK, Verduin CJ (1983). The combined effects of an antihistamine and pseudoephidrine on human performance. J Drug Res 8 (7): 1929-1936.
15. Gaillard AWK, Gruisen A, De Jong R (1988). The influence of antihistamines on human performance. Eur J Clin Pharmacol 35: 249-253.
16. Geyer MA, Krebs-Thomson K, Braff DL, Swerdlow NR (2001). Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review. Psychopharmacology (Bert) 156 (2-3): 117-154. (Pubitemid 32702206)
17. Hindmarch I, Shamsi Z (1999). Antihistamines: models to assess sedative properties, assessment of sedation, safety and other side-effects. Clin Exp Allergy 29 (Suppl. 3): 133-142. (Pubitemid 29333347)
18. Jasper HH (1957). The ten-twenty electrode system of the international federation. Electroencephalogr Clin Neurophysiol 10: 371-375.
19. Jex HR, McDonnell JD, Phatak AV (1966). A 'critical' tracking task for man-machine research related to the operator's effective delay time. I. Theory and experiments with a first-order divergent controlled element. NASA CR-616. NASA Contract Rep NASA CR: 1-105.
20. de Jong R, Wierda M, Mulder G, Mulder LJ (1988). Use of partial stimulus information in response processing. J Exp Psychol Hum Percept Perform 14 (4): 682-692.
21. Leufkens TR, Vermeeren A, Smink BE, van Ruitenbeek P, Ramaekers JG (2007). Cognitive, psychomotor and actual driving performance in healthy volunteers after immediate and extended release formulations of alprazolam 1 mg. Psychopharmacology (Berl) 191 (4): 951-959. (Pubitemid 46399138)
22. Loring DW, Meador KJ (1989). Central nervous system effects of antihistamines on evoked potentials. Ann Allergy 63 (6 Pt 2): 604-608.
23. McCarthy G, Donchln E (1981). A metric for thought: a comparison of P300 latency and reaction time. Science 211 (4477): 77-80.
24. Meador KJ, Loring DW, Thompson EE, Thompson WO (1989). Differential cognitive effects of terfenadine and chlorpheniramine. J Allergy Clin Immunol 84 (3): 322-325. (Pubitemid 19243973)
25. Miller J, Hackley SA (1992). Electrophysiological evidence for temporal overlap among contingent mental processes. J Exp Psychol Gen 121 (2): 195-209.
26. Miller J, van der Ham F, Sanders AF (1995). Overlapping stage models and reaction time additivity: effects of the activation equation. Acta Psychol (Amst) 90 (1-3): 11-28.
27. Miller J, Patterson T, Ulrich R (1998). Jackknife-based method for measuring LRP onset latency differences. Psychophysiology 35 (1): 99-115. (Pubitemid 28036086)
28. Northoff G, Pfennig A, Krug M, Danos P, Leschinger A, Schwarz A et al. (2000). Delayed onset of late movement-related cortical potentials and abnormal response to lorazepam in catatonia. Schizophr Res 44 (3): 193-211. (Pubitemid 30657957)
29. Olkkola KT, Ahonen J (2008). Midazolam and other benzodiazepines. Handb Exp Pharmacol 182: 335-360.
30. Onodera K, Yamatodani A, Watanabe T, Wada H (1994). Neuropharmacology of the histaminergic neuron system in the brain and its relationship with behavioral disorders. Prog Neurobiol 42 (6): 685-702. (Pubitemid 24199522)
31. Osman A, Bashore TR, Coles MG, Donchin E, Meyer DE (1992). On the transmission of partial information: inferences from movementrelated brain potentials. J Exp Psychol Hum Percept Perform 18 (1): 217-232.
32. Pang E, Fowler B (1.994). Discriminating the effects of triazolam on stimulus and response processing by means of reaction time and P300 latency. Psychopharmacology (Berl) 115 (4): 509-515.
33. Passani MB, Bacciottini L, Mannaioni PF, Blandina P (2000). Central histaminergic system and cognition. Neurosci Biobehav Rev 24 (1): 107-113.
34. Polich J (2007). Updating P300: an integrative theory of P3a and P3b. Clin Neurophysiol 118 (10): 2128-21.48.
35. Pompeia S, Manzano GM, Galduroz JC, Tufik S, Bueno OF (2003). Lorazepam induces an atypical dissociation of visual and auditory event-related potentials. J Psychopharmacol 17 (1): 31-40. (Pubitemid 36373138)
36. Pooviboonsuk P, Dalton JA, Curran HV, Lader MH (1996). The effects of single doses of lorazepam on event related potentials and cognitive function. Hum Psychopharmacol 11: 241-252. (Pubitemid 26251728)
37. Ramaekers JG, O'Hanlon JF (1994). Acrivastine, terfenadine and diphenhydramine effects on driving performance as a function of dose and time after dosing. Eur J Clin Pharmacol 47 (3): 261-266.
38. Riba J, Rodriguez-Fornells A, Munte TF, Barbanoj MJ (2005). A neurophysiological study of the detrimental effects of alprazolam on human action monitoring. Brain Res Cogn Brain Res 25 (2): 554-565. (Pubitemid 41443359)
39. Riedel WJ, Mehta M, Unema P (2006). Human cognition assessment in drug research. Curr Pharm Des 12: 1.-15.
40. Robbe HWJ, O'Hanlon JF (1990). Effects of acrivastine, acrivastine plus pseudoephidrine and triprolidine on highway driving. Maastricht. Report no. IGVG 90-12.
41. Rockstroh B, Elbert T, Lutzenberger W, Altenmuller E (1991). Effects of the anticonvulsant benzodiazepine clonazepam on event-related brain potentials in humans. Electroencephalogr Clin Neurophysiol 78 (2): 142-149.
42. Sanders AF (1980). Stage analysis of reaction processes. In: Stelmach GE, Requin J (eds). Tutorials in Motor Behavior. North-Holland: Amsterdam, pp. 331-354.
43. Seidl R, Hauser E, Bernert G, Marx M, Freilinger M, Lubec G (1997). Auditory evoked potentials in young patients with Down syndrome. Event-related potentials (P3) and histaminergic system. Brain Res Cogn Brain Res 5 (4): 301-309. (Pubitemid 27244954)
44. Semlitsch HV, Anderer P, Schuster P, Presslich O (1986). A solution for reliable and valid reduction of ocular artifacts, applied to the P300 ERP. Psychophysiology 23 (6): 695-703. (Pubitemid 17014356)
45. Simons FE, Reggin JD, Roberts JR, Simons KJ (1994). Benefit/risk ratio of the antihistamines (Hl-receptor antagonists) terfenadine and chlorpheniramine in children. J Pediatr 124 (6): 979-983.
46. Smulders FT, Kok A, Kenemans JL, Bashore TR (1995). The temporal selectivity of additive factor effects on the reaction process revealed in ERP component latencies. Acta Psychol (Amst) 90 (1-3): 97-109.
47. Smulders FT, Kenemans JL, Schmidt WF, Kok A (1999). Effects of task complexity in young and old adults: reaction time and P300 latency are not always dissociated. Psychophysiology 36 (1): 118-125.
48. Sternberg S (1969). The discovery of processing stages: extensions of donders' method. Acta Psychol (Amst) 30: 276-315.
49. Theunissen EL, Vermeeren A, van Oers AC, van Maris I, Ramaekers JG (2004). A dose-ranging study of the effects of mequitazine on actual driving, memory and psychomotor performance as compared to dexchlorpheniramine, cetirizine and placebo. Clin Exp Allergy 34 (2): 250-258. (Pubitemid 38315262)
50. Turner C, Handford AD, Nicholson AN (2006). Sedation and memory: studies with a histamine H-I receptor antagonist. J Psychopharmacol 20 (4): 506-517. (Pubitemid 43875180)
51. Ulrich R, Miller J (2001). Using the jackknife-based scoring method for measuring LRP onset effects in factorial, designs. Psychophysiology 38 (5): 816-827. (Pubitemid 32848144)
52. Van Ruitenbeek P, Vermeeren A, Riedel W (2008). Histamine Hireceptor blockade in humans affects psychomotor performance but not memory. J Psychopharmacol 22 (6): 663-672.
53. Vermeeren A, Ramaekers JG, O'Hanlon JF (2002). Effects of emedastine and cetirizine, alone and with alcohol, on actual driving of males and females. J Psychopharmacol 16 (1): 57-64. (Pubitemid 34273074)
54. Verster JC, Volkerts ER (2004). Antihistamines and driving ability: evidence from on-the-road driving studies during normal traffic. Ann Allergy Asthma Immunol 92 (3): 294-303; quiz 303-295, 355.
55. Vuurman EF, Uiterwijk MM, Rosenzweig P, O'HanlonJF (1994). Effects of mizolastine and clemastine on actual driving and psychomotor performance in healthy volunteers. Eur J Clin Pharmacol 47 (3): 253-259.
56. Witkin JM, Nelson DL (2004). Selective histamine H3 receptor antagonists for treatment of cognitive deficiencies and other disorders of the central nervous system. Pharmacol Ther 103 (1): 1-20.
57. Yanai K, Tashi.ro M (2007). The physiological and pathophysiological roles of neuronal histamine: an insight from human positron emission tomography studies. Pharmacol Ther 113 (1): 1-15.